Beneficial hemodynamic effects of dipyridamole on portal circulation in cirrhosis

American Journal of Gastroenterology

Volumn 93, Issue 3, 1998, Pages 429-433

  Sansoè, Giovanni ^a   Ferrari, Alberto ^a   D'Alimonte, Piero ^a   Trenti, Tommaso ^a   Zoboli, Patrizia ^a   Romagnoli, Renato ^a   Villa, Erica ^a   Manenti, Federico ^a  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

DIPYRIDAMOLE;

ADULT; AGED; ARTICLE; BLOOD FLOW VELOCITY; CLINICAL ARTICLE; DRUG EFFECT; FEMALE; HUMAN; LIVER BLOOD FLOW; LIVER CIRRHOSIS; LIVER CLEARANCE; MALE; PORTAL VEIN BLOOD FLOW; PRIORITY JOURNAL; VASODILATATION;

ADMINISTRATION, ORAL; ADULT; AGED; DIPYRIDAMOLE; FEMALE; HEMODYNAMIC PROCESSES; HUMANS; LIVER CIRCULATION; LIVER CIRRHOSIS; MALE; MIDDLE AGED; PORTAL VEIN; SORBITOL; TIME FACTORS;

EID: 0032033968     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9270(97)00118-4     Document Type: Article

References (34)

1. 1. Navasa M, Bosch J, Chesta J, et al. Reduction of portal pressure by isosorbide-5-mononitrate in patients with cirrhosis. Gastroenterology 1989;96:1110-8.
2. 2. Kong CW, Lay CS, Lai KH, et al. The hemodynamic effect of verapamil on portal hypertension in patients with post-necrotic cirrhosis. Hepatology 1986;6:423-6.
3. 3. Iwao T, Toyonaga A, Ikegami M, et al. Nicardipine infusion improved hepatic function but failed to reduce hepatic venous pressure gradient in patients with cirrhosis. Am J Gastroenterol 1992;3:326-31.
4. 4. Albillos A, Lledò JL, Bañares R, et al. Hemodynamic effects of α-adrenergic blockade with prazosin in cirrhotic patients with portal hypertension. Hepatology 1994;20:611-7.
5. 5. Hadengue A, Lee S, Moreau R, et al. Beneficial hemodynamic effects of ketanserin in patients with cirrhosis: Possible role of serotonergic mechanisms in portal hypertension. Hepatology 1987;7:644-7.
6. 6. Brown BG, Josephson MA, Peterson RB, et al. Intravenous dipyridamole combined with isometric handgrip for near maximal acute increase in coronary flow in patients with coronary artery disease. Am J Cardiol 1981;48:1077-85.
7. 7. Wang T, Mentzer RM Jr, Van Wylen DGL. Interstitial adenosine with dipyridamole: Effect of adenosine receptor blockade and adenosine deaminase. Am J Physiol 1992;263:H552-8.
8. 8. FitzGerald GA. Dipyridamole. N Engl J Med 1987;316:1247-57.
9. 9. Lautt WW, Greenway CV. Conceptual review of the hepatic vascular bed. Hepatology 1987;7:952-63.
10. 10. Lautt WW, Legare DJ. The use of 8-phenyltheophylline as a competitive antagonist of adenosine and an inhibitor of the intrinsic regulatory mechanism of the hepatic artery. Can J Physiol Pharmacol 1985;63: 717-22.
11. 11. Lautt WW, Legare DJ, d'Almeida MS. Adenosine as putative regulator of hepatic arterial flow (the buffer response). Am J Physiol 1985;248: H331-8.
12. 12. Siringo S, Bolondi L, Gaiani S, et al. The relationship of endoscopy, portal Doppler ultrasound flowmetry, and clinical and biochemical tests in cirrhosis. J Hepatol 1994;20:11-8.
13. 13. Siringo S, Bolondi L, Gaiani S, et al. Timing of the first variceal hemorragein cirrhotic patients: Prospective evaluation of Doppler flowmetry, endoscopy and clinical parameters. Hepatology 1994;20: 66-73.
14. 14. Pugh RNH, Murray-Lyon IM, Dawson JL, et al. Transaction of the esophagus for bleeding esophageal varices. Br J Surg 1973;60:646-9.
15. 15. Zeeh J, Lange H, Bosch J, et al. Steady-state extrarenal sorbitol clearance as a measure of hepatic plasma flow. Gastroenterology 1988;95:749-59.
16. 16. Mahony C, Wolfram KM, Cocchetto DM, et al. Dipyridamole kinetics. Clin Pharmacol Ther 1982;31:330-8.
17. 17. Moriyasu F, Nishida O, Ban N, et al. "Congestion Index" of the portal vein. AJR 1986;146:735-9.
18. 18. Lafortune M, Dauzat M, Pomier-Layrargues G, et al. Hepatic artery: Effect of a meal in healthy persons and transplant recipients. Radiology 1993;187:391-4.
19. 19. SAS Institute. SAS user's guide: statistics. Cary, NC: SAS Institute Inc., 1982; 139-99.
20. 20. Lehmann CR, Locke K, Pierson WP, et al. Persantine bioavailability problems. Clin Pharm 1984;3:14-5.
21. 21. Iwao T, Toyonaga A, Ikegami M, et al. Effects of vasopressin and nicardipine on hemodynamics and liver function in patients with cirrhosis: Comparison with vasopressin alone. J Hepatol 1993;19:345-52.
22. 22. Reichen J, Le M. Verapamil favorably influences hepatic microvascular exchange and function in rats with cirrhosis of the liver. J Clin Invest 1986;78:448-55.
23. 23. Dagenais M, Pomier-Layrargues G, Rocheleau B, et al. Systemic and splanchnic hemodynamic effects of pentifylline in rats with portal hypertension. Clin Sci 1992;83:41-5.
24. 2 restores the depressed hepatocellular function and hepatic blood flow following hemorrage and resuscitation. J Surg Res 1991:50:368-74.
25. 25. Sabbà C, Merkel C, Zoli M, et al. Interobserver and interequipment variability of Echo-Doppler examination of the portal vein: Effect of a cooperative training program. Hepatology 1995;21:428-33.
26. 26. Okazaki K, Miyazaki M, Onishi S, et al. Effects of food intake and various extrinsic hormones on portal blood flow in patients with liver cirrhosis demonstrated by pulsed Doppler with the Octoson. Scan J Gastroenterol 1986;21:1029-38.
27. 27. Li Bassi S, Bolondi L, Gaiani S, et al. Effects of secretin on portal venous flow. Gastroenterology International 1A 570 (suppl), XIII International Congress of Gastroenterology, Rome, Sept. 4-10, 1988.
28. 28. Moreau R, Champigneulle B, Gaudin C, et at. Effects of theophylline on hemodynamics and tissue oxygenation in patients with cirrhosis. J Hepatol 1992;15:323-9.
29. 29. Murakami S, Bernardo JF, Branch RA, et al. Adenosine does not mediate renal sodium retention and peripheral vasodilation elicited by portal vein ligation in rats. Hepatology 1996;23:346-52.
30. 30. Lagerkranser M, Irestedt L, Sollevi A, et al. Central and splanchnic hemodynamics in the dog during controlled hypotension with adenosine. Anesthesiology 1984;60:547-52.
31. 31. Nukina S, Fusaoka T, Thurman RG. Glycogenolytic effects of adenosine involves ATP from hepatocytes and eicosanoids from Kuppfer cells. Am J Physiol 1994;266:G99-105.
32. 2 release from primary Ito cell cultures after stimulation with noradrenaline and ATP but not adenosine. Hepatology 1994;20:142-8.
33. 33. Westfall TC. Local regulation of adrenergic neurotransmission. Physiol Rev 1977;57:659-728.
34. 34. Hashimoto H, Watanabe T, Shiratori Y, et al. Prostanoid secretion by rat hepatic sinusoidal endothelial cells and its regulation by exogenous adenosine triphosphate. Hepatology 1995;21:1713-8.